Tedisamil increases coherence during ventricular fibrillation and decreases defibrillation energy requirements

Cardiovascular Research

Volumn 33, Issue 2, 1997, Pages 485-494

  Dorian, Paul ^a   Newman, David ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

defibrillation; electrophysiology; tedisamil; ventricular fibrillation

Indexed keywords

TEDISAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; HEART VENTRICLE FIBRILLATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; COMBINED MODALITY THERAPY; CYCLOPROPANES; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HEART; HUMANS; MIDDLE AGED; VENTRICULAR FIBRILLATION;

EID: 0031015102     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00214-3     Document Type: Article

References (37)

1. Wang M, Dorian P. DL and D sotalol decrease defibrillation energy requirements. PACE 1989;12:1522-1529.
2. Beatch GN, Dickenson DR, Davis DR, Tang ASL. Dofetilide: relationship between refractory period extension and defibrillation threshold. PACE 1995;18:820(Abstract).
3. Murakawa Y, Sezake K, Inoue H, et al. Shock-induced refractory period extension and pharmacologic modulation of defibrillation threshold. J Cardiovasc Pharmacol 1994;23:822-825.
4. Echt DS, Black JN, Barbey JT, Coxe DR, Cato E. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. Circulation 1989;79:1106-1117.
5. Dorian P, Wang M, David I, Feindel C. Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model. Circulation 1991;83:614-621.
6. Dorian P, Witkowski FX, Penkoske PA, Feder-Elituv RS. Barium decreases defibrillation energy requirements. J Cardiovasc Pharmacol 1994;23:107-112.
7. Dillon SM. Synchronized repolarization after defibrillation shocks. A possible component of the defibrillation process demonstrated by optical recordings in rabbit heart. Circulation 1992;85:1865-1878.
8. Sweeny RJ, Gill RM, Steinberg MI, Reid PR. Ventricular refractory period extension caused by defibrillation shocks. Circulation 1990;82:965-972.
9. Witkowski FX, Plonsey R, Penkoske PA, Kavanaugh KM. Significance of inwardly directed transmembrane current in determination of local myocardial electrical activation during ventricular fibrillation. Circ Res 1994;74:507-524.
10. Ideker RE, Zhou X, Knisley S. Correlation among fibrillation, defibrillation and cardiac pacing. PACE 1995;18:512-525.
11. Dorian P, Penkoske PA, Witkowski FX. Order in disorder: effect of barium on ventricular fibrillation. Can J Cardiol 1996;12:399-406.
12. Dorian P, Newman D. Effect of sotalol on ventricular fibrillation and defibrillation in humans. Am J Cardiol 1993;72:72A-79A.
13. Bargheer K, Bode F, Klein HU, Trappe HJ, Franz MR, Lichtlen PR. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium blocking agent. Eur Heart J 1994;15:1409-1414.
14. + current in rat ventricular myocytes. Am J Physiol 1989;257:H1746-H1749.
15. + currents in mammalian cardiac and glial cells. J Pharmacol Exp Ther 1990;254:560-569.
16. Opthof T, Anand R, Misier RC, et al. Dispersion of refractoriness in canine ventricular myocardium. Effects of sympathetic stimulation. Circ Res 1991;68:1204-1215.
17. K1 blockade: a new antiarrhythmic mechanism? Circulation 1993;87:1979-1989.
18. to blockade? J Cardiovasc Pharmacol 1991;18:445-456.
19. Ropella KM, Sahakian AV, Baerman JM, Swiryn S. The coherence spectrum. A quantitative discriminator of fibrillatory and nonfibrillatory cardiac rhythms. Circulation 1989;80:112-119.
20. Ropella KM, Baerman JM, Sahakian AV, Swiryn S. Differentiation of ventricular tachyarrhythmias. Circulation 1990;82:2035-2043.
21. Throne RD, Windle JR, Easley ARJ, Olshansky B, Wilber D. Scatter diagram analysis: a new technique for discriminating ventricular tachyarrhythmias. PACE 1994;17:1267-1275.
22. Jones DL, Irish WD, Klein GJ. Defibrillation efficacy: comparison of defibrillation threshold versus dose-response curve determination. Circ Res 1991;69:45-51.
23. Cha Y, Peters BB, Chen P. The effects of lidocaine on the vulnerable period during ventricular fibrillation. J Cardiovasc Electrophysiol 1994;5:571-580.
24. Kaplan DT, Cohen RT. Is fibrillation chaos? Circ Res 1990;886-892.
25. Carlisle EJF, Allen JD, Kernohan WG, Anderson J, Adgey AJ. Fourier analysis of ventricular fibrillation of varied aetiology. Eur Heart J 1990;11:173-181.
26. Grohs JG, Fischer G, Raberger G. Cardiac and hemodynamic effects of the selective bradycardic agent KC 8857 during exercise-induced myocardial ischemia. Eur J Pharmacol 1989;161:53-60.
27. Labhasetwar V, Underwood T, Heil RWJ, Gallagher M, Landberg J, Levy RJ. Epicardial administration of ibutilide from polyurethane matrices: effects of defibrillation threshold and electrophysiologic parameters. J Cardiovasc Pharmacol 1994;24:826-840.
28. Bailey WM, Fukaye E, Weinberger J, Colamesta R, Frame VB, Nademanee K. MK-499, a new class III agent, reduces defibrillation threshold in patients with chronically implanted cardioverter defibrillators. PACE 1995;18:835(Abstract).
29. Chi L, Park JL, Friedrichs GS, Banglawala YA, Perez MA, Tanhehco EJ, Lucchesi BR. Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart. Br J Pharmacol 1996;117:1261-1269.
30. Bril A, Landais L, Gout B. Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo. Cardiovasc Drugs Ther 1993;7:233-240.
31. + current bloker. Br J Pharmacol 1991;102:13-18.
32. Damle R, Kanaan NM, Robinson NS, Ge Y, Goldberger JJ, Kadish AH. Spatial and temporal linking of epicardial activation directions during ventricular fibrillation in dogs. Evidence for underlying organization. Circulation 1992;86:1547-1558.
33. Bayly PV, Johnson EE, Wolf PD, Greenside HS, Smith WM, Ideker RE. A quantitative measurement of spatial order in ventricular fibrillation. J Cardiovasc Electrophysiol 1993;4:533-546.
34. Witkowski F, Kavanagh K, Penkoske P, et al. In vivo transmembrane cardiac current determination provides evidence for unstable fixed points during ventricular fibrillation. Can J Cardiol 1994;10:94C(Abstract).
35. Abildskov JA. Additions to the wavelet hypothesis of cardiac fibrillation. J Cardiovasc Electrophysiol 1994;5:553-559.
36. Dorian P, Newman D, Tang A, Green M. D Sotalol decreases defibrillation energy requirements in humans: a prospective controlled study. PACE 1994;17:828(Abstract).
37. Dorian P, Witkowski FX, Penkoske P. Order in disorder: mechanism of barium induced lowering of defibrillation energy requirements. Circulation 1991;84:II-498(Abstract).